rs10521307 (FTO): BMI and pancreatic gene expression

Key takeaways

  • rs10521307 is in the FTO gene region, one of the most replicated genetic regions tied to body mass index
  • In pancreatic tissue, carriers of the alt allele show reduced expression of the nearby IRX3 gene
  • BMI-associated genetic variants collectively link to more than 300 distinct diagnoses, spanning cardiovascular, kidney, and respiratory conditions
  • Evidence for BMI associations draws from genome-wide analyses of over 1.1 million people

Key takeaways

  • rs10521307 is in the FTO gene region, one of the most replicated genetic regions tied to body mass index
  • In pancreatic tissue, carriers of the alt allele show reduced expression of the nearby IRX3 gene
  • BMI-associated genetic variants collectively link to more than 300 distinct diagnoses, spanning cardiovascular, kidney, and respiratory conditions
  • Evidence for BMI associations draws from genome-wide analyses of over 1.1 million people

What the research says A large-scale meta-analysis identified 906 genome-wide significant loci for body mass index (BMI, a measure of weight relative to height) in approximately 1.1 million European-ancestry participants and 41 loci in approximately 100,000 African-ancestry participants, including the FTO region where rs10521307 is located. Using Mendelian randomization (a method that uses genetic variants as proxies for lifetime exposure to a trait to help assess causal relationships) with a 2,446-variant BMI genetic risk score, 316 distinct diagnoses were associated with higher genetically predicted BMI in the Million Veteran Program biobank, with 96.5% showing increased risk. Tissue-level expression data from GTEx v11 shows that carriers of the alt allele have reduced expression of IRX3 and ENSG00000287885 specifically in pancreatic tissue GTEx Portal.

Reported associations

  • Body mass index: rs10521307 is in the FTO gene region, a locus captured within a genome-wide scan of approximately 1.1 million European-ancestry participants that identified 906 independent BMI-associated loci
  • Heart failure, ischemic heart disease, and atrial fibrillation: Mendelian randomization using BMI genetic instruments identified associations with these cardiovascular outcomes; rs10521307 is one component of the 2,446-variant BMI instrument used
  • Chronic renal failure: Among the 316 diagnoses associated with genetically elevated BMI in the Million Veteran Program phenome-wide analysis
  • Respiratory failure and asthma: Also represented among the 316 BMI-associated diagnoses spanning multiple organ systems
  • Musculoskeletal and dermatologic conditions: Included in the interconnected disease communities identified through co-morbidity network analysis of the broader BMI genetic architecture
  • Type 2 diabetes mellitus and coronary heart disease: Named explicitly as leading comorbidities tied to the BMI genetic architecture in Mendelian randomization analyses
  • Pancreatic IRX3 expression: The alt allele is associated with reduced IRX3 expression in pancreatic tissue (slope -0.35, p=3.3e-6) GTEx Portal
  • Pancreatic ENSG00000287885 expression: The alt allele is also associated with reduced expression of ENSG00000287885 in pancreatic tissue (slope -0.31, p=4.2e-5) GTEx Portal

Evidence quality BMI GWAS findings for the FTO region draw on a meta-analysis of approximately 1.1 million European-ancestry and approximately 100,000 African-ancestry participants, providing substantial statistical power for discovery. The available study does not report an effect size or p-value for rs10521307 in isolation; it is characterized as part of the broader genome-wide scan. The 316-diagnosis phenome-wide study used a 2,446-variant genetic risk score, so reported disease associations reflect the joint effect of many BMI variants rather than this locus alone; individual variant contributions are not disaggregated. Replication was conducted via meta-analysis incorporating the UK Biobank and other large consortia. Tissue-specific expression evidence comes from GTEx v11 eQTL data (expression quantitative trait loci, which measure how genetic variants influence nearby gene activity; 953 donors, cis-window, FDR below 0.05); these are mechanistic findings and eQTL effects on gene expression are not equivalent to clinical outcomes.

Tissue-specific expression effects

  • IRX3: The alt allele is associated with reduced expression of IRX3 in pancreatic tissue GTEx Portal
  • ENSG00000287885: The alt allele is also associated with reduced expression of ENSG00000287885 in pancreatic tissue GTEx Portal

Lifestyle considerations No lifestyle considerations on file for this variant.

Frequently asked questions

What is the FTO gene?

FTO is a gene linked to body mass index that has been identified consistently in large-scale genetic studies. A meta-analysis involving over 1.1 million people found this region among 906 genome-wide significant BMI loci.

What does rs10521307 do?

rs10521307 is a variant in the FTO gene region associated with body mass index. In pancreatic tissue, data from GTEx show the alt allele is linked to reduced expression of the nearby IRX3 gene and a second gene in the same region.

What is IRX3 and why does it appear here?

IRX3 is a gene near FTO in the same chromosomal neighborhood. Tissue-level data from GTEx v11 show that carriers of the alt allele of rs10521307 have reduced IRX3 activity specifically in the pancreas. This is a mechanistic finding; its clinical significance is not established by the available studies.

Is rs10521307 linked to diseases beyond BMI?

Large genetic studies using many BMI variants together have found associations with more than 300 diagnoses, including heart failure, chronic kidney disease, and asthma. These findings reflect the combined effect of thousands of BMI variants, not this one locus alone.

How strong is the evidence for this variant?

The FTO region as a BMI locus is supported by genome-wide data from over 1.1 million people. The pancreatic gene expression evidence comes from GTEx v11 with 953 donors. Effect sizes specific to rs10521307 in isolation are not reported in the available study.